Literature DB >> 9415515

Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma.

Gary J McCleane1.   

Abstract

This case report describes the successful alleviation of the pain of pancreatic carcinoma with intravenous phentolamine mesylate. A 2 day infusion gave relief for 26 days on the first occasion and for 12 weeks after the second infusion. The possible mode of action is discussed.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9415515     DOI： 10.1016/S0304-3959(97)00096-1

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


  3 in total

1.  Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion.

Authors:  Tao Wang; Fu-Zhou Tian; Zhong-Hong Cai; Xu Li; Tao Cheng; Li Shi; Qi Cheng
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

2.  Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma.

Authors:  Masako Yasukawa; Ken'ichi Yasukawa; You Kamiizumi; Ryouji Yokoyama
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

3.  Pain management in pancreatic cancer.

Authors:  Mariam Hameed; Haroon Hameed; Michael Erdek
Journal:  Cancers (Basel)       Date:  2010-12-24       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.